Key result
Atrial fibrillation catheter ablation was associated with a significant reduction in patients receiving at least one ICD therapy compared to pre-ablation.
Why the study?
Does catheter ablation of atrial fibrillation reduce ICD therapies in patients with ischaemic or dilated cardiomyopathy?
Observational (n=73)
Does catheter ablation of atrial fibrillation reduce ICD therapies in patients with ischaemic or dilated cardiomyopathy?
Catheter ablation of atrial fibrillation in patients with cardiomyopathy and an ICD is associated with a significant reduction in both appropriate and inappropriate ICD therapies and an improvement in LVEF.
Answers are grounded in this paper and cite their sources.
Supports AF ablation to reduce ICD therapies in cardiomyopathy; extends observational data but leaves open need for RCTs.
AIMS: Atrial fibrillation (AF) is associated with frequent appropriate and inappropriate implantable cardioverter defibrillator (ICD) therapies. Catheter ablation of AF has been shown to reduce AF burden and improve left ventricular function in heart failure patients but the impact on ICD therapies has not yet been studied. The aim of this study was to test the hypothesis that AF ablation reduces ICD therapies in patients with cardiomyopathies. METHODS AND RESULTS: In 73 consecutive patients (mean age 59 ± 10 years, 85% male) with previously implanted ICD due to ischaemic (n = 30) or dilated cardiomyopathy (n = 43) undergoing AF ablation, the prevalence and frequency of ICD therapies before and after AF ablation were compared. During the total follow-up of 3.3 ± 3 years prior to AF ablation, 5.1 ± 14.7 therapies per patient-year were delivered as opposed to 1.8 ± 10.9 in a period of 1.1 ± 0.9 years after ablation (P = 0.002). Prior to AF ablation, 39 patients (53%) received at least one ICD therapy when compared with 15 patients (21%) after ablation. Atrial fibrillation ablation was associated with freedom from any therapy regardless of appropriateness (odds ratio, OR, 0.366, CI 0.164-0.816, P = 0.014, adjusted for follow-up). Appropriate shocks significantly decreased from 0.3 ± 1.3 to 0.1 ± 0.5 per patient-year (P = 0.030). While heart failure medication and use of antiarrhythmic drugs were comparable during the entire follow-up, a statistically significant improvement of left ventricular ejection fraction (LVEF) from 36.9 ± 12.3% to 40.7 ± 6.7% (P = 0.008) was observed after AF ablation. CONCLUSIONS: In patients with ischaemic or dilated cardiomyopathy, catheter ablation of AF is associated with the reduction of inappropriate and appropriate ICD therapies and improvement of LVEF.
No takes yet. Share an insight, caveat, or question.
Kosiuk et al. (2014) conducted an observational in Atrial fibrillation and ischaemic or dilated cardiomyopathy (n=73). Atrial fibrillation catheter ablation vs. Pre-ablation period was evaluated on Receiving at least one ICD therapy (OR 0.366, 95% CI 0.164-0.816, p=0.014). Atrial fibrillation catheter ablation was associated with a significant reduction in patients receiving at least one ICD therapy compared to pre-ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: